Pharmacological Cardioversion in Patients with Recent-Onset Atrial Fibrillation and Chronic Kidney Disease Subanalysis of the CANT II Study

Pharmacological cardioversion (PCV) is commonly a primary option for termination of recent-onset atrial fibrillation (AF) in emergency departments (ED). This is a subanalysis of the CANT II study, evaluating the effectiveness and safety of antazoline in patients (n = 777) at three stages of chronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceynowa-Sielawko, Beata, Wybraniec, Maciej T., Topp-Zielińska, Aleksandra, Maciąg, Aleksander, Miśkowiec, Dawid, Balsam, Paweł, Wójcik, Maciej, Wróbel, Wojciech, Farkowski, Michał M., Ćwiek-Rębowska, Edyta, Ozierański, Krzysztof, Błaszczyk, Robert, Bula, Karolina, Dembowski, Tomasz, Peller, Michał, Krzowski, Bartosz, Wańha, Wojciech, Koziński, Marek, Kasprzak, Jarosław D., Szwed, Hanna, Mizia-Stec, Katarzyna, Szołkiewicz, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025387/
https://www.ncbi.nlm.nih.gov/pubmed/35457747
http://dx.doi.org/10.3390/ijerph19084880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025387/
https://www.ncbi.nlm.nih.gov/pubmed/35457747
http://dx.doi.org/10.3390/ijerph19084880

Ejemplares similares